Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 1, 2003, Pages 83-86

  Cairns, Andrew P ^b   Crockard, Alistair D ^a   Bell, Aubrey L ^b  

^a ROYAL GROUP OF HOSPITALS   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Interleukin 10 receptor; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE TEST; LEUKOCYTE; MALE; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; SEVERITY OF ILLNESS INDEX;

EID: 0346035926     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ALLAVENA P, PIEMONTI L, LONGONI D et al.: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998; 28: 359-69.
2. HASHIMOTO S, YAMADA M, MOTOYOSHI K, AKAGAWA KS: Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997; 89: 315-21.
3. BUCHWALD UK, GEERDES-FENGE HF, VOCKLER J, ZIEGE S, LODE H: Interleukin-10: Effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone. Eur J Med Res 1999; 4: 85-94.
4. DE VRIES JE: Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995; 27: 537-41.
5. LAI CF, RIPPERGERJ, MORELIA KK et al.: Receptors for interleukin (IL)-10 and IL6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem 1996; 271: 13968-75.
6. DEAN GS, TYRRELL-PRICE J, CRAWLEY E, ISENBERG DA: Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000; 59: 243-51.
7. LAZARUS M, HAJEER AH, TURNER D et al.: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-7.
8. NAKASHIMA H, AKAHOSHI M, TANAKA Y et al.: Polymorphisms within the interleukin-10 receptor cDNA gene (IL-10R) in Japanese patients with systemic lupus erythematosus. Rheumatology 1999; 38: 1142-4.
9. ANDERSEN LS, PETERSEN J, SVENSON M, BENDTZEN K: Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity 1999; 30: 235-42.
10. HOUSSIAU FA, LEFEBVRE C, VANDEN BERGHE M, LAMBERT M, DEVOGELAER JP, RENAULD JC: Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4: 393-5.
11. PARK YB, LEE SK, KIM DS, LEE J, LEE CH, SONG CH: Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16: 283-8.
12. LIANG NIH, SOCHER SA, LARSON MG, SCHUR PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.
13. PREVOO NIL, VAN'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
14. LACKI JK, SAMBORSKI W, MACKIEWICZ SH: Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 1997; 16: 275-8.
15. CAIRNS AP, CROCKARD AD, MCCONNELL JR, COURTNEY PA, BELL AL: Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: Relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 2001; 60: 950-5.